TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 ...
Preliminary U.S. BRIUMVI fourth quarter and full year 2024 net product revenue of $103.6 million and $310 million, respectivelyFull Year 2025 ...